107 results
Page 3 of 6
424B5
6yh2b12addlh
24 Mar 22
Prospectus supplement for primary offering
4:15pm
PRE 14A
90enxtz49j18pgzxous
1 Sep 21
Preliminary proxy
4:46pm
424B5
a2558r
20 Aug 21
Prospectus supplement for primary offering
4:46pm
S-8
n5ad6o7a gz
30 Jun 21
Registration of securities for employees
4:02pm
S-8
EX-5.1
3xo6hf 2jnvewzwilrru
30 Jun 21
Registration of securities for employees
4:02pm
8-K
t5a6 sr0ss
10 Jun 21
Submission of Matters to a Vote of Security Holders
5:30pm
8-K
EX-10.1
izia6z
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-10.1
4b88p5 6hn
13 Oct 20
Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
9:30am
8-K
EX-1.1
z0ev8m56ak40t3x05
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
424B4
i4opsaokd
5 Oct 20
Prospectus supplement with pricing info
4:16pm